Vulinacimab (Anti-VEGFR2 / KDR / CD309)
A3110
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameVulinacimab (Anti-VEGFR2 / KDR / CD309)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionVulinacimab (Anti-VEGFR2 / KDR / CD309) is a monoclonal antibody targeting VEGFR-2. It has potential anti-angiogenesis and antineoplastic activities and can be used in the research of cancers. MW :145.38 KD.
- Storage Instruction-20°C
- UNSPSC12352203